Earnings call: Bio-Techne sees growth in Q3 with strong market positioning By Investing.com

Bio-Techne (NASDAQ: [TECH](/equities/techne-corp)) Corporation (NASDAQ: TECH) reported a 2% year-over-year organic revenue growth for the third quarter of fiscal year 2024, with a notable increase in adjusted operating margin to 33%.
Read more...